Exenatide vs Pramlintide

A side-by-side comparison from PeptideSciences101, the open peptide reference.

Overview

Exenatide and Pramlintide are both weight management & metabolic peptides, but they differ in mechanism, dosing, and regulatory status.

This page compares Exenatide and Pramlintide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

ExenatidePramlintide
CategoryWeight Management & MetabolicWeight Management & Metabolic
Regulatory status (US)FDA approvedResearch use only
Typical dosage5–10 mcg (Byetta) or 2 mg (Bydureon/Bydureon BCise)60-120 mcg
FrequencyTwice daily (Byetta) or once weekly (Bydureon)with meals
Reported benefitsGlycemic control (HbA1c reduction 0.8–1.9 percentage points), modest body weight reduction (2–4 kg), low intrinsic hypoglycemia risk, modest systolic blood pressure reduction, cardiovascular non-inferiority established in EXSCELReduced post-meal glucose, weight loss, appetite control
Reported side effectsNausea, vomiting, diarrhea, injection site reactions, hypoglycemia (when co-administered with sulfonylureas), rare acute pancreatitis, rare acute kidney injuryNausea, hypoglycemia risk with insulin

Key differences

Primary use. Exenatide is categorised under Weight Management & Metabolic, while Pramlintide falls under Weight Management & Metabolic. Because they target a similar goal, they are common alternatives to weigh against each other.

Regulatory status. Exenatide: FDA-approved. Pramlintide: not FDA-approved; treated as a research compound.

Dosing. Exenatide is typically dosed at 5–10 mcg (Byetta) or 2 mg (Bydureon/Bydureon BCise) (Twice daily (Byetta) or once weekly (Bydureon)). Pramlintide is typically dosed at 60-120 mcg (with meals).

Can you stack them?

Some protocols combine peptides, but stacking Exenatide and Pramlintide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between Exenatide and Pramlintide?
Exenatide and Pramlintide are both weight management & metabolic peptides, but they differ in mechanism, dosing, and regulatory status. Exenatide is FDA-approved for one or more indications, whereas Pramlintide is not FDA-approved; generally classified as a research compound.
What is Exenatide used for?
FDA-approved GLP-1 receptor agonist for type 2 diabetes; the first incretin mimetic approved in the US.
What is Pramlintide used for?
Amylin analog for diabetes.
Can you take Exenatide and Pramlintide together?
Some users combine peptides within a single protocol, but stacking Exenatide and Pramlintide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
Is Exenatide or Pramlintide FDA-approved?
Exenatide is FDA-approved for one or more indications. Pramlintide is not FDA-approved; generally classified as a research compound.

Read the full articles

  • Exenatide — full monograph: mechanism, research, dosing & references
  • Pramlintide — full monograph: mechanism, research, dosing & references

More Weight Management & Metabolic comparisons

← All peptide comparisons